1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Goodfellow, B.J. Dias, J.S. Ferreira, G.C. Wray, V. Henklein, P. Macedo, A.L. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking NE FEBS Lett. FEBLAL 0165 0014-5793 505 325 10.1016/S0014-5793(01)02818-6 11566198 The Solution Structure and Heme Binding of the Presequence of Murine 5-Aminolevulinate Synthase 2001 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 2586.189 AMINOLEVULINIC ACID SYNTHASE 2, ERYTHROID 2.3.1.37 PRESEQUENCE RESIDUES 1-26 1 syn polymer AMINO LEVULINATE SYNTHASE, 5-AMINOLEVULINIC ACID SYNTHASE, DELTA-AMINOLEVULINATE SYNTHASE, DELTA-ALA SYNTHETASE no no MVAAAMLLRSCPVLSQGPTGLLGKVA MVAAAMLLRSCPVLSQGPTGLLGKVA A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n repository Initial release Version format compliance Version format compliance 1 0 2001-10-18 1 1 2011-05-08 1 2 2011-07-13 PDBE Y PDBE 2001-07-08 REL 10090 MUS MUSCULUS sample 150MS NOESY, 70MS TOCSY LOW TARGET FUNCTION 20 15 NOESY COSY TOCSY 5 pH 303 K torsion angle dynamics 1 GUNTERT,WUTHRICH refinement DYANA structure solution DYANA 600 Bruker DMX MET 1 n 1 MET 1 A VAL 2 n 2 VAL 2 A ALA 3 n 3 ALA 3 A ALA 4 n 4 ALA 4 A ALA 5 n 5 ALA 5 A MET 6 n 6 MET 6 A LEU 7 n 7 LEU 7 A LEU 8 n 8 LEU 8 A ARG 9 n 9 ARG 9 A SER 10 n 10 SER 10 A CYS 11 n 11 CYS 11 A PRO 12 n 12 PRO 12 A VAL 13 n 13 VAL 13 A LEU 14 n 14 LEU 14 A SER 15 n 15 SER 15 A GLN 16 n 16 GLN 16 A GLY 17 n 17 GLY 17 A PRO 18 n 18 PRO 18 A THR 19 n 19 THR 19 A GLY 20 n 20 GLY 20 A LEU 21 n 21 LEU 21 A LEU 22 n 22 LEU 22 A GLY 23 n 23 GLY 23 A LYS 24 n 24 LYS 24 A VAL 25 n 25 VAL 25 A ALA 26 n 26 ALA 26 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 6 A A O OXT LEU ALA 22 26 2.08 9 A A O H LEU LYS 21 24 1.54 1 A VAL 2 -164.62 -157.62 1 A LEU 8 -91.31 48.33 1 A ARG 9 -58.60 -92.12 1 A GLN 16 69.28 64.76 1 A THR 19 80.29 -57.45 2 A ALA 3 -110.57 59.43 2 A ALA 5 -159.63 -45.24 2 A MET 6 -88.82 40.32 2 A LEU 7 -154.48 -47.72 2 A PRO 12 -75.06 -84.28 2 A LEU 14 -178.94 97.40 2 A LYS 24 -117.40 52.37 3 A ALA 4 -144.80 -48.22 3 A MET 6 -37.77 -36.92 3 A LEU 7 -94.73 -61.33 3 A LEU 8 38.54 64.81 3 A SER 10 -176.72 59.87 3 A VAL 13 -125.32 -95.20 3 A GLN 16 -119.07 65.01 3 A THR 19 167.04 -31.11 3 A LYS 24 -155.86 78.36 4 A ALA 3 -141.09 54.17 4 A ALA 4 -64.25 -72.93 4 A LEU 8 -143.73 49.46 4 A SER 10 43.48 28.00 4 A CYS 11 46.96 88.90 4 A LEU 14 -173.35 -62.17 4 A PRO 18 -75.05 -70.57 4 A THR 19 167.79 -39.37 4 A LEU 21 -136.50 -54.17 4 A LYS 24 -166.27 83.60 5 A VAL 2 -166.56 -157.58 5 A ALA 3 -106.41 47.89 5 A ALA 4 -147.15 58.96 5 A ALA 5 -157.30 -47.09 5 A MET 6 -88.49 38.77 5 A LEU 7 -151.27 -47.15 5 A LEU 8 -117.90 60.24 5 A CYS 11 39.18 65.06 5 A VAL 13 -158.89 -45.20 5 A LEU 14 77.75 -56.19 5 A SER 15 176.50 -60.09 5 A LEU 21 -91.27 49.64 6 A ALA 3 -161.34 58.37 6 A PRO 12 -75.01 -72.25 6 A LEU 14 -174.28 -67.53 6 A SER 15 -173.72 -57.38 6 A THR 19 38.81 76.80 6 A VAL 25 -105.72 -107.70 7 A ALA 4 40.45 29.85 7 A ALA 5 -160.31 -47.98 7 A LEU 8 51.25 81.82 7 A SER 10 169.78 41.37 7 A CYS 11 43.20 76.65 7 A LEU 14 52.10 94.77 7 A THR 19 80.39 -52.71 7 A VAL 25 -108.81 -107.93 8 A VAL 2 -170.36 -157.61 8 A ALA 3 -98.22 53.08 8 A ALA 4 -109.85 59.81 8 A ALA 5 -165.18 -43.71 8 A MET 6 -89.09 37.26 8 A LEU 7 -149.21 -48.64 8 A LEU 8 -105.69 49.80 8 A SER 10 -140.46 55.92 8 A LEU 14 56.74 89.73 8 A THR 19 80.01 -53.31 8 A LEU 22 -122.00 -97.31 8 A VAL 25 -105.51 -107.62 9 A VAL 2 -95.77 -156.74 9 A LEU 8 -87.90 46.44 9 A CYS 11 63.11 151.28 9 A SER 15 58.68 158.67 9 A VAL 25 -103.29 -107.40 10 A ALA 3 -108.29 60.15 10 A LEU 8 -150.06 -52.22 10 A LEU 21 -150.72 -67.04 10 A LYS 24 -96.53 33.13 10 A VAL 25 -123.12 -107.95 11 A ALA 3 -111.87 68.65 11 A ALA 4 -159.41 39.38 11 A ALA 5 -133.75 -47.15 11 A MET 6 -88.38 39.34 11 A LEU 7 -160.36 -45.51 11 A SER 10 -169.01 67.01 11 A VAL 13 -140.64 -95.18 11 A LEU 14 77.75 -56.29 11 A GLN 16 65.19 161.41 11 A VAL 25 -103.37 -107.33 12 A ALA 4 -177.24 52.28 12 A ALA 5 -172.41 -49.80 12 A LEU 8 -92.47 44.10 12 A GLN 16 -167.47 72.70 12 A LEU 22 -165.16 32.37 12 A LYS 24 -99.64 32.24 12 A VAL 25 -103.41 -107.36 13 A ALA 4 178.62 55.02 13 A ALA 5 178.75 -52.00 13 A LEU 8 -100.28 51.33 13 A SER 10 -143.91 -58.51 13 A LEU 14 -174.89 -53.48 13 A SER 15 -179.85 136.04 13 A GLN 16 64.47 139.67 13 A PRO 18 -75.00 -70.36 13 A THR 19 167.05 -80.90 13 A LEU 22 68.09 -96.69 13 A VAL 25 -115.91 -107.89 14 A ALA 4 -135.63 -47.41 14 A ALA 5 -91.26 40.91 14 A ARG 9 -93.89 38.53 14 A CYS 11 44.00 81.35 14 A LEU 14 62.36 77.59 14 A PRO 18 -75.01 -70.34 14 A THR 19 167.84 -37.83 14 A LEU 21 -120.09 -58.34 14 A LYS 24 -159.86 80.76 14 A VAL 25 -103.32 -107.35 15 A ALA 4 -126.95 -53.16 15 A LEU 8 -111.41 56.40 15 A SER 10 48.11 24.19 15 A CYS 11 63.30 151.02 15 A VAL 13 -136.65 -95.20 15 A THR 19 38.96 74.59 15 A LEU 21 -124.51 -68.96 15 A LEU 22 -40.58 104.56 15 A VAL 25 -103.41 -107.39 AMINOLEVULINIC ACID SYNTHASE 2, ERYTHROID (E.C.2.3.1.37) Solution structure of the 26 aa presequence of 5-ALAS 1 N N ACYLTRANSFERASE ACYLTRANSFERASE, ALAS, PRESEQUENCE Q64452 UNP 1 Q64452 1 26 1H7J 1 26 Q64452 A 1 1 26 1 P 1